SecBot SecBot
PRESS-RELEASE ·Filed May 15, 2026

LFWD

Lifeward Ltd.
BEARISH
Impact 7/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The massive EPS miss is largely non-cash and non-recurring, but the 22% revenue decline and 38% AlterG drop signal real operational headwinds from working capital constraints. The delayed 10-Q filing adds uncertainty. Watch for the Q2/Q3 shipment catch-up on secured AlterG orders and the ORMD-0801 Phase 2 trial start as potential catalysts. The $11.4M cash position provides a runway, but the company is burning ~$3.7M/quarter in operations.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.70
T+0 close · May 15, 2026 · via day close
Latest settled
+12.91%
T+60 · $7.57
Vs SPY
+8.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $6.70entry
  2. T+1 · 6mo ago −1.79%α −1.73% · $6.58
  3. T+5 · 6mo ago +5.22%α +4.26% · $7.05
  4. T+20 · 5mo ago +3.81%α +1.69% · $6.96
  5. T+60 · 3mo ago +12.91%α +8.40% · $7.57
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lifeward reported Q1 2026 revenue of $3.9M (down 22% YoY) and a GAAP net loss of $10.8M ($6.70/share), massively missing the single-analyst consensus EPS estimate of -$0.34. The headline miss is driven by a one-time $4.9M non-cash acquired in-process R&D charge from the Oratech acquisition, but core operations also weakened: AlterG revenue fell 38% due to working capital constraints, gross margin contracted to 34.2% from 42.2%, and the GAAP operating loss more than doubled to $10.3M. The company delayed its 10-Q filing, adding uncertainty.

Key Financial Metrics

EPS
−$6.70
est −$0.34 · -958.8%
Revenue
$3.9M
est $5.8M · -32.4% · -22.1% YoY
Rating
strong miss
Gross Margin
34.2%

Key Facts

  • Revenue fell 22% YoY to $3.9M, missing the $5.8M consensus
  • GAAP EPS of -$6.70 vs consensus -$0.34, a 958.8% miss driven by a $4.9M non-cash IPR&D charge from the Oratech acquisition
  • Non-GAAP adjusted net loss was $5.1M ($3.13/share), compared to $4.6M ($5.28/share) in Q1 2025
  • AlterG revenue declined 38% to $2.1M due to working capital constraints affecting sourcing and supply chain
  • Gross margin contracted to 34.2% from 42.2% YoY, driven by lower production volumes, tariffs, and FX
  • Cash used in operations improved to $3.7M from $5.5M YoY; cash balance rose to $11.4M from $2.2M at year-end 2025, boosted by $10M financing and $6.5M cash from Oratech acquisition
  • Company delayed filing of its Q1 2026 10-Q, citing need for additional time to finalize accounting related to the strategic transaction
  • ReWalk personal exoskeleton sales increased 11% to $1.6M; MyoCycle FES bike sales flat at $0.2M
  • Weighted average shares outstanding nearly doubled to 1.6M from 0.87M YoY, reflecting the reverse split and equity issuance

Financial Impact

Revenue miss of ~$1.9M (33% below consensus); GAAP EPS miss of $6.36 vs consensus; operating loss doubled to $10.3M; gross margin down 800 bps

revenueepsgross marginoperating losscash flow

Risk Factors

  • Delayed 10-Q filing may trigger Nasdaq listing compliance concerns or covenant issues
  • Working capital constraints continue to impair AlterG supply chain and revenue
  • Integration of Oratech and execution on the oral insulin pipeline are unproven
  • Dilution from the convertible notes and warrant liabilities ($6.8M) could pressure the stock
  • Revenue concentration in AlterG (54% of total) leaves the company exposed to further supply chain disruptions

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3295802

Track record

25 reports on LFWD

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
  2. Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
  4. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
  5. Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
  6. Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
  7. Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
  8. Aug 14, 202613w ago 8-K Mixed 6/10 No price data
  9. Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
  10. Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 9h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026